CIPLA ETORICOXIB etoricoxib 60 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 60 mg tablet blister pack

cipla australia pty ltd - etoricoxib, quantity: 60 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

CIPLA ETORICOXIB etoricoxib 60 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 60 mg tablet bottle

cipla australia pty ltd - etoricoxib, quantity: 60 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

CIPLA ETORICOXIB etoricoxib 30 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 30 mg tablet blister pack

cipla australia pty ltd - etoricoxib, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

CIPLA ETORICOXIB etoricoxib 120 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 120 mg tablet blister pack

cipla australia pty ltd - etoricoxib, quantity: 120 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

ARCOXIA TABLET 60 mg Singapore - English - HSA (Health Sciences Authority)

arcoxia tablet 60 mg

organon singapore pte. ltd. - etoricoxib - tablet, film coated - 60 mg - etoricoxib 60 mg

ARCOXIA etoricoxib 60mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

arcoxia etoricoxib 60mg tablet blister pack

organon pharma pty ltd - etoricoxib, quantity: 60 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; iron oxide yellow - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

ARCOXIA etoricoxib 30mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

arcoxia etoricoxib 30mg tablet blister pack

organon pharma pty ltd - etoricoxib, quantity: 30 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; carnauba wax; croscarmellose sodium; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

CIPLA ETORICOXIB etoricoxib 90 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 90 mg tablet bottle

cipla australia pty ltd - etoricoxib, quantity: 90 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

CIPLA ETORICOXIB etoricoxib 90 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 90 mg tablet blister pack

cipla australia pty ltd - etoricoxib, quantity: 90 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

CIPLA ETORICOXIB etoricoxib 30 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cipla etoricoxib etoricoxib 30 mg tablet bottle

cipla australia pty ltd - etoricoxib, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - cipla etoricoxib is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.